Research location
Cuernavaca
Morelos, Mexico
Advertisement
Research activity in Cuernavaca
Morelos, MexicoCureCurrent currently publishes aggregate city-level research activity for this location: 84 trials and 85 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cuernavaca
84 linked trials · page 2 of 2Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) PatientsNCT01020123 · 2009-10-01 · 1 site observation
COMPLETED
Supplementation With Vitamin D Improves Leptin ResistanceNCT00907270 · 2009-09-01 · 1 site observation
UNKNOWN
An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 DiabetesNCT00960076 · 2009-08-01 · 1 site observation
COMPLETED
Study of Immunotherapy to Treat Advanced Prostate CancerNCT00861614 · 2009-05-01 · 1 site observation
COMPLETED
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsNCT00856544 · 2009-05-01 · 1 site observation
COMPLETED
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesNCT00859898 · 2009-04-01 · 1 site observation
COMPLETED
Water Beverage Intervention Trial for Reducing Risk Factors of Metabolic Syndrome in Young Mexican Free Living WomenNCT01245010 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 DiabetesNCT00860288 · 2009-02-01 · 1 site observation
COMPLETED
Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican WomenNCT02247635 · 2008-11-01 · 1 site observation
COMPLETED
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast CancerNCT00667251 · 2008-10-07 · 1 site observation
COMPLETED
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid ArthritisNCT00665925 · 2008-05-01 · 1 site observation
COMPLETED
Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone HealthNCT00679939 · 2008-04-21 · 1 site observation
COMPLETED
Vitamin D, C-reactive Protein and Insulin ResistanceNCT01019642 · 2008-03-01 · 1 site observation
COMPLETED
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active ComparatorNCT00631007 · 2008-02-01 · 1 site observation
COMPLETED
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)NCT00637273 · 2008-01-01 · 1 site observation
COMPLETED
A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid ArthritisNCT00550446 · 2007-09-01 · 1 site observation
COMPLETED
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-NaiveNCT00495469 · 2007-08-17 · 1 site observation
COMPLETED
A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionNCT00696384 · 2007-06-01 · 1 site observation
COMPLETED
Study of Rivoglitazone in Type 2 Diabetes MellitusNCT00484198 · 2007-04-23 · 1 site observation
COMPLETED
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid ArthritisNCT00413699 · 2007-02-05 · 1 site observation
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00327015 · 2006-05-01 · 1 site observation
COMPLETED
A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With SulfonylureasNCT00313313 · 2006-04-01 · 1 site observation
COMPLETED
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1cNCT00294723 · 2006-02-01 · 1 site observation
TERMINATED
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal DiseaseNCT00296400 · 2006-02-01 · 1 site observation
COMPLETED
A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusNCT00263276 · 2005-12-01 · 1 site observation
COMPLETED
C-Reactive Protein (CRP) in Obese Diabetic WomenNCT00262548 · 2005-10-01 · 1 site observation
COMPLETED
Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation
COMPLETED
A Study In Patients With Type 2 Diabetes MellitusNCT00256867 · 2005-08-18 · 1 site observation
COMPLETED
Remission and Joint Damage Progression in Early Rheumatoid ArthritisNCT00122382 · 2005-07-01 · 1 site observation
COMPLETED
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin AloneNCT00095030 · 2004-02-01 · 1 site observation
COMPLETED
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 DiabeticsNCT00240370 · 2003-10-01 · 1 site observation
COMPLETED
PPAR - Combination With MetforminNCT00162240 · 2003-06-01 · 1 site observation
COMPLETED
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlNCT00246987 · 2003-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.